The global ultrasound market is growing from a roughly $10B base in the mid-2020s toward a substantially larger market over the next decade, driven by rising demand for diagnostic imaging, point-of-care systems and therapeutic ultrasound. North America was the largest regional share recently, while Asia–Pacific shows the fastest forecasted growth. Diagnostic (cart-based) systems currently dominate revenue, but handheld/portable and therapeutic ultrasound segments are the fastest-growing. Hospitals remain the largest end-user, with imaging centers and women’s-health (OB/GYN) applications expanding rapidly.
Download the free sample and get the full report for complete insights and forecasts on this market @ https://www.towardshealthcare.com/download-sample/5563
GE HealthCare (GE Healthcare)
◉Strengths: Longstanding global market leader in broad clinical portfolio, deep installed base, strong partnerships with large hospitals, heavy investment in AI/clinical-workflow tools and breast & women’s-health imaging.
◉Notable products: Voluson family (women’s-health / 3D/4D), LOGIQ series (general & vascular imaging), Vivid (cardiac), Invenia ABUS (automated breast ultrasound), and the Versana/Venue series for mid-to-point-of-care.
◉Why it matters: broad product depth (from high-end radiology/cardiac to point-of-care), large service/support network and frequent software/AI updates.
Philips (Koninklijke Philips N.V.)
◉Strengths: Strong emphasis on workflow, quantitative tools and AI features; well-known for image quality in cardiology and women’s health plus a competitive handheld offering for POC use.
◉Notable products: EPIQ / EPIQ Elite (high-end imaging), Affiniti (mid-range), Lumify (handheld, phone/tablet-connected point-of-care). Philips also pushes AI-assisted measurement/workflows to speed exams.
Siemens Healthineers
◉Strengths: High engineering emphasis on image quality and advanced AI tools for specific workflows (cardiac, abdomen, MSK), large global sales/service footprint and integration with broader imaging diagnostics.
◉Notable products: ACUSON Sequoia (premium deep-penetration imaging and AI features), ACUSON Juniper / Redwood lines for general imaging and shared-service environments. Recently introduced AI-driven features (e.g., “AI Abdomen”).
Canon Medical Systems (Canon / Toshiba legacy)
◉Strengths: Strong physics/beamforming and penetration performance (noted in cardiology and abdominal imaging); focuses on image clarity, ergonomics and productivity features; well-regarded in hospitals and cardiology labs.
◉Notable products: Aplio i-series / Aplio a-series (high-performance general and cardiac imaging), Prism/Aplio innovations with advanced beam/processing tech.
Mindray Medical
◉Strengths: Competitive pricing, expanding global footprint (especially in emerging markets), fast product cadence and strong value across mid-range and premium segments. Good adoption in ambulatory and hospital settings where cost matters.
◉Notable products: Resona series (premium systems such as Resona A20 launched 2024), DC/Expert and general imaging portfolios for varied clinical uses.
Samsung Medison (Samsung Healthcare)
◉Strengths: Strong R&D in women’s health and advanced imaging features, good ergonomics and image-processing capabilities; tight integration with Samsung’s broader healthcare/display/IT ecosystem.
◉Notable products: HERA family (women’s-health premium platform), high-performance shared-service systems and novel probes; active product showcases at RSNA/industry shows.
FUJIFILM SonoSite (Fujifilm point-of-care / SonoSite)
◉Strengths: Leader in rugged, reliable point-of-care and bedside ultrasound (durability, simplicity, quick boot times)—favored by emergency, critical care, military and ambulatory use. Good reputation for portability and reliability.
◉Notable products: Edge II, X-Porte and other compact/portable SonoSite systems focused on POC workflows.
Esaote
◉Strengths: Specialist European vendor focused on musculoskeletal (MSK), small-parts, vascular, and veterinary niches; known for ergonomic consoles, automated measurement workflows, and competitive premium imaging in specific applications.
◉Notable products: MyLab family (e.g., MyLab X7, MyLab E80, MyLab X90) with automation/zero-click features and solutions tailored for MSK, cardiology and vascular use.
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5563
Access our exclusive, data-rich dashboard dedicated to the diagnostics sector – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
The global ultrasound market is valued at USD 10.1 billion in 2024 and is expected to grow to USD 20.34… Read More
The global natural language processing (NLP) in healthcare and life sciences market is experiencing rapid growth, valued at USD 6.66… Read More
The global nurse call systems market was valued at USD 2.2 billion in 2024 and is expected to grow significantly,… Read More
The bioprocess containers market is in rapid expansion driven by strong adoption of single-use technologies across biopharma manufacturing, rising biologics… Read More
The global infant formula market is expanding rapidly, driven by rising disposable incomes in Asia-Pacific, premiumisation of products, and growth… Read More
The NLP in healthcare & life-sciences market is rapidly expanding — several market reports place the industry at roughly USD… Read More